OptimizeRx Corporation
OPRX
$9.20
-$0.79-7.91%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -14.48% | -75.81% | -24.83% | -28.36% | -53.57% |
| Total Depreciation and Amortization | 82.86% | 116.34% | 102.72% | 56.47% | 23.49% |
| Total Amortization of Deferred Charges | 295.73% | 860.54% | 554.74% | 766.67% | -- |
| Total Other Non-Cash Items | -18.31% | 62.59% | 24.62% | 25.21% | 43.82% |
| Change in Net Operating Assets | 104.32% | -266.79% | -1,289.72% | -1,190.90% | -492.57% |
| Cash from Operations | 167.53% | -186.03% | -149.47% | -177.62% | -167.96% |
| Capital Expenditure | -28.74% | -1.73% | -29.80% | 5.76% | -7.41% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -4,047.35% | -4,047.35% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -100.61% | 405.64% | 198.22% | 198.23% | 198.31% |
| Cash from Investing | 98.22% | -47.76% | 49.83% | 59.87% | 56.45% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -133.92% | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -91.15% | -95.88% | -85.85% | -85.00% |
| Repurchase of Common Stock | 88.56% | 95.20% | 97.27% | 60.73% | 60.24% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 200.00% | -- | -- | -- |
| Cash from Financing | -117.40% | 321.32% | 226.60% | 243.28% | 248.91% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -200.00% | -- | -- | -- |
| Net Change in Cash | 89.17% | 119.75% | 106.64% | 98.26% | 93.45% |